SCHEMBL7216010

SCHEMBL7216010

N=C(N)c1cc2ccc(OC(=O)c3ccco3)cc2o1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 14/20 0.67
HSD17B10 Q99714 4/20 0.60
ALDH1A1 P00352 2/20 0.60
KDM4E B2RXH2 5/20 0.57
MAPT P10636 4/20 0.57
GAA P10253 4/20 0.57
GLA P06280 3/20 0.57
USP2 O75604 1/20 0.57
S1PR2 O95136 1/20 0.57
S1PR4 O95977 1/20 0.57
HPGD P15428 1/20 0.57
S1PR1 P21453 1/20 0.57
CASP1 P29466 1/20 0.57
CASP7 P55210 1/20 0.57
F2 P00734 2/20 0.52
MEN1 O00255 2/20 0.49
ESR1 P03372 1/20 0.49
POLB P06746 1/20 0.49
MAPK1 P28482 1/20 0.49
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7623105 0.93 KMT2A (0.59) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL7623795 0.83 KMT2A (0.53) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL11043060 0.82 KMT2A (0.68) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL7219824 0.78 KMT2A (0.72) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL11474052 0.78 KMT2A (0.68) KMT2AHSD17B10ALDH1A1MAPTHPGD
SCHEMBL7219896 0.77 C1S (0.66) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL28063309 0.74 KMT2A (0.78) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL7623913 0.74 KMT2A (0.59) KMT2AALDH1A1KDM4EMAPTGAA
SCHEMBL13381577 0.73 KMT2A (0.75) KMT2AHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL13791553 0.72 KMT2A (0.85) KMT2AHSD17B10ALDH1A1MAPTF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653340-B1 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway BIOCRYST PHARMACEUTICALS, INC. 2003-11-25 US disclosed
EP-1066272-A4 NOVEL COMPOUNDS USEFUL IN THE COMPLEMENT, COAGULAT AND KALLIKREIN PATHWAYS AND METHOD FOR THEIR PREPARATION BIOCRYST PHARM INC (US) 2002-03-13 EP disclosed
EP-1066272-A1 NOVEL COMPOUNDS USEFUL IN THE COMPLEMENT, COAGULAT AND KALLIKREIN PATHWAYS AND METHOD FOR THEIR PREPARATION BIOCRYST PHARMACEUTICALS INC. (US) 2001-01-10 EP disclosed
WO-1998055471-A1 NOVEL COMPOUNDS USEFUL IN THE COMPLEMENT, COAGULAT AND KALLIKREIN PATHWAYS AND METHOD FOR THEIR PREPARATION BIOCRYST PHARMACEUTICALS, INC. (US) 1998-12-10 WO disclosed